Biochips Based In-Vitro Diagnostics Market, By Product Type (Consumables, Instruments, and Software & Services), By Application, By End-User, By Technology, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5222
|
Published Date
May 2026
|
Pages
333
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Biochips Based In-Vitro Diagnostics Market size was valued at US$ 7,360.8 Million in 2025, expanding at a CAGR of 9.1% from 2026 to 2033.
Biochip-based in-vitro diagnostics (IVD) are advanced laboratory testing methods that use miniature biological chips to analyze blood, tissue, saliva, or other bodily samples outside the human body. These biochips enable multiple tests to be performed simultaneously on a compact platform, helping healthcare professionals detect infections, genetic disorders, cancer biomarkers, and metabolic conditions more quickly and accurately. Common technologies used in these diagnostics include microarrays, biosensors, and lab-on-chip systems.
The adoption of these diagnostics is gradually increasing as healthcare systems place greater emphasis on early disease detection, personalized treatment, and rapid testing solutions. This growth is further supported by stronger regulatory oversight and public health preparedness initiatives. For example, the U.S. Food and Drug Administration highlights the importance of in-vitro diagnostics in clinical decision-making and maintains structured approval pathways for such technologies. Additionally, post-pandemic demand for molecular diagnostics has further accelerated their adoption. Similarly, in Europe and Switzerland, updated in-vitro diagnostic regulations have been introduced to improve patient safety, strengthen quality management systems, and encourage innovation in reliable diagnostic technologie
Biochips Based In-Vitro Diagnostics Market- Market Dynamics
Expansion of digital laboratory transformation and point-of-care testing is driving market growth
Healthcare systems are playing a key role in advancing biochip-based in-vitro diagnostics by making diagnostic processes faster, more connected, and more accessible. Modern laboratories are increasingly transitioning from manual, time-intensive workflows to automated and digitally integrated systems, where biochip technologies enable multiple tests to be performed simultaneously with greater efficiency and accuracy. For example, India’s Ayushman Bharat Digital Mission is supporting the integration of digital health infrastructure across the healthcare ecosystem. In China, the National Medical Products Administration is strengthening regulatory frameworks to support the adoption of digital diagnostic solutions.
In Japan, the Ministry of Health, Labour and Welfare is advancing the modernization of clinical testing environments through structured digital health initiatives that improve efficiency and data connectivity in diagnostics. On the industry side, companies such as Sysmex Corporation are developing advanced automated hematology and diagnostic systems to enhance laboratory workflow efficiency, while Becton Dickinson is expanding point-of-care testing solutions that enable faster diagnostic decisions directly at patient locations.
Biochips Based In-Vitro Diagnostics Market- Segmentation Analysis:
The Global Biochips Based In-Vitro Diagnostics Market is segmented on the basis of Product Type, Application, End-User, Technology, and Region.
The market is segmented into three categories based on product type: consumables, instruments, and software. Consumables remain widely used due to their reliance on recurring usage of reagents, cartridges, and test kits, which support continuous diagnostic workflows in laboratories and clinical settings. These products are essential for each testing cycle, making them a consistent requirement across healthcare facilities utilizing molecular and chip-based diagnostic systems. Companies such as QIAGEN have strengthened their contributions in consumables by expanding cartridge-based sample preparation and molecular testing solutions. Similarly, bioMérieux has enhanced the production and deployment of single-use diagnostic reagent kits to support faster infectious disease detection and improve laboratory efficiency.
The market is also segmented by end-user into research institutions, hospitals and clinics, and diagnostic centers. Among these, hospitals and clinics account for a significant share, as they serve as the primary point of patient care where rapid and accurate diagnostic decisions are critical. These facilities manage large patient volumes with diverse medical conditions, increasing their reliance on advanced diagnostic tools that deliver quick results and support timely treatment decisions. Companies such as Roche Diagnostics have expanded their hospital-focused molecular testing platforms to enable integrated diagnostic workflows in clinical environments. Likewise, Siemens Healthineers has strengthened its hospital laboratory solutions by developing automated diagnostic systems designed to improve workflow efficiency and support faster clinical decision-making
Biochips Based In-Vitro Diagnostics Market- Geographical Insights
Regional analysis of the biochips-based in-vitro diagnostics market highlights how healthcare innovation and diagnostic adoption vary depending on scientific capability, infrastructure, and regulatory support. Among global regions, North America plays a leading role due to its strong research ecosystem, well-established regulatory framework, and high adoption of precision diagnostic technologies. The National Institutes of Health has supported large-scale precision medicine and genomic research programs, including major initiatives focused on molecular profiling for cancer and chronic disease studies. In addition, the U.S. Food and Drug Administration provides structured approval pathways for advanced in-vitro diagnostic devices, enabling faster introduction of biochip-based technologies into clinical practice.
Furthermore, reimbursement support from the Centers for Medicare & Medicaid Services (CMS) for molecular diagnostic procedures has further encouraged adoption within healthcare systems. From an industry perspective, Thermo Fisher Scientific has expanded biochip-enabled genomic and proteomic platforms used in both research and clinical diagnostics, while Illumina continues to strengthen sequencing-based biochip solutions supported by large-scale genomic research and precision medicine initiatives.
UK Biochips Based In-Vitro Diagnostics Market- Country Insights
The United Kingdom demonstrates steady and structured growth in the biochips-based in-vitro diagnostics market, supported by a well-established public healthcare system, strong research funding, and a regulatory environment that encourages early adoption of advanced diagnostic technologies. The country places significant emphasis on early disease detection, personalized treatment approaches, and the integration of advanced diagnostic tools into routine clinical practice. The National Health Service has expanded the use of genomic and molecular testing through its Genomic Medicine Service, supporting the broader integration of precision diagnostics into everyday healthcare delivery. In addition, the Department of Health and Social Care has increased investment in life sciences innovation under its Life Sciences Vision policy, aimed at accelerating the development and adoption of advanced diagnostic technologies, including microarray and biochip-based systems.
Furthermore, the UK Health Security Agency continues to strengthen national diagnostic capabilities by enhancing laboratory surveillance and molecular testing for infectious disease monitoring. From an industry perspective, Oxford Nanopore Technologies is advancing chip-based sequencing platforms that enable rapid genomic analysis. Together, these government initiatives and industry innovations provide a strong foundation for diagnostic advancement and clinical adoption in the United Kingdom.
Biochips Based In-Vitro Diagnostics Market- Competitive Landscape:
The Biochips-based in-vitro diagnostics market is evolving into a science-driven healthcare ecosystem where medical technology companies, biotechnology developers, and diagnostic solution providers collaborate to advance disease detection and improve patient care. Growth in this field is being supported by the increasing use of genetic testing, rapid screening technologies, and lab-on-chip systems, which enable faster, more accurate diagnostic outcomes. Healthcare institutions, research laboratories, and diagnostic centers are steadily adopting these solutions to enhance clinical decision-making and improve workflow efficiency.
This sector is further shaped by continuous innovation in microarray systems, biosensors, and automated molecular platforms, supported by collaborations between industry players, research organizations, and healthcare networks.
Key market participants include Illumina, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, and Danaher Corporation, all of which are contributing to advancements in biochip-enabled diagnostic technologies. For example, Illumina has strengthened its genomic testing ecosystem by improving chip-based sequencing workflows to support more precise applications in precision medicine. Similarly, Agilent Technologies has enhanced its microarray platforms to improve sensitivity in biomarker detection, particularly in oncology and disease research.
Recent Developments:
- In June 2025, Bio-Rad Laboratories expanded its collaboration with research institutions to develop next-generation chip-based multiplex diagnostic assays. These assays enable simultaneous detection of multiple disease markers from a single sample, improving diagnostic efficiency and supporting earlier disease detection across clinical and research settings.
- In March 2025, Roche Diagnostics expanded its molecular diagnostics portfolio by strengthening collaborations with clinical laboratories to integrate next-generation biochip-enabled PCR systems. This advancement supports faster infectious disease detection, improves laboratory efficiency, and enhances molecular testing through integrated biochip-based technologies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
- Illumina
- Bio-Rad Laboratories
- PerkinElmer
- QIAGEN
- Danaher Corporation
- GE HealthCare
- Siemens Healthineers
- bioMérieux
- Becton Dickinson
- Merck KGaA
- Standard BioTools
- DiaSorin
- Tecan Group
- Randox Laboratories
- HORIBA
- LI-COR Biosciences
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Consumables
- Reagents & Kits
- Biochips/Microarrays
- Instruments
- Chip Readers & Scanners
- PCR Systems
- Microfluidic Devices
- Others
- Software & Services
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Lab-On-Chip Applications
- DNA Applications
- Protein Microarrays
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033
- Research Institutions
- Hospitals and Clinics
- Diagnostic Centers
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Microarray Technology
- Biosensor Technology
- PCR-Integrated Biochips
- Nanotechnology-Based Chips
- Microfluidics-Based Systems
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Biochips Based In-Vitro Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Biochips Based In-Vitro Diagnostics Market Snippet by Product Type
2.1.2. Biochips Based In-Vitro Diagnostics Market Snippet by Application
2.1.3. Biochips Based In-Vitro Diagnostics Market Snippet by End-User
2.1.4. Biochips Based In-Vitro Diagnostics Market Snippet by Technology
2.1.5. Biochips Based In-Vitro Diagnostics Market Snippet by Country
2.1.6. Biochips Based In-Vitro Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Biochips Based In-Vitro Diagnostics Key Market Trends
3.1. Biochips Based In-Vitro Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Biochips Based In-Vitro Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Biochips Based In-Vitro Diagnostics Market Opportunities
3.4. Biochips Based In-Vitro Diagnostics Market Future Trends
4. Biochips Based In-Vitro Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Biochips Based In-Vitro Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Biochips Based In-Vitro Diagnostics Market Landscape
6.1. Biochips Based In-Vitro Diagnostics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Biochips Based In-Vitro Diagnostics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Consumables
7.1.2.1. Reagents & Kits
7.1.2.2. Biochips/Microarrays
7.1.3. Instruments
7.1.3.1. Chip Readers & Scanners
7.1.3.2. PCR Systems
7.1.3.3. Microfluidic Devices
7.1.3.4. Others
7.1.4. Software & Services
7.1.5. Others
8. Biochips Based In-Vitro Diagnostics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Lab-On-Chip Applications
8.1.3. DNA Applications
8.1.4. Protein Microarrays
8.1.5. Others
9. Biochips Based In-Vitro Diagnostics Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2025 & 2033 (%)
9.1.2. Research Institutions
9.1.3. Hospitals and Clinics
9.1.4. Diagnostic Centers
9.1.5. Others
10. Biochips Based In-Vitro Diagnostics Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
10.1.2. Microarray Technology
10.1.3. Biosensor Technology
10.1.4. PCR-Integrated Biochips
10.1.5. Nanotechnology-Based Chips
10.1.6. Microfluidics-Based Systems
10.1.7. Others
11. Biochips Based In-Vitro Diagnostics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Biochips Based In-Vitro Diagnostics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Biochips Based In-Vitro Diagnostics Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Abbott Laboratories
12.2.2. Agilent Technologies
12.2.3. Thermo Fisher Scientific
12.2.4. F. Hoffmann-La Roche
12.2.5. Illumina
12.2.6. Bio-Rad Laboratories
12.2.7. PerkinElmer
12.2.8. QIAGEN
12.2.9. Danaher Corporation
12.2.10. GE HealthCare
12.2.11. Siemens Healthineers
12.2.12. bioMérieux
12.2.13. Becton Dickinson
12.2.14. Merck KGaA
12.2.15. Standard BioTools
12.2.16. DiaSorin
12.2.17. Tecan Group
12.2.18. Randox Laboratories
12.2.19. HORIBA
12.2.20. LI-COR Biosciences
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
- Illumina
- Bio-Rad Laboratories
- PerkinElmer
- QIAGEN
- Danaher Corporation
- GE HealthCare
- Siemens Healthineers
- bioMérieux
- Becton Dickinson
- Merck KGaA
- Standard BioTools
- DiaSorin
- Tecan Group
- Randox Laboratories
- HORIBA
- LI-COR Biosciences
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Consumables
- Reagents & Kits
- Biochips/Microarrays
- Instruments
- Chip Readers & Scanners
- PCR Systems
- Microfluidic Devices
- Others
- Software & Services
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Lab-On-Chip Applications
- DNA Applications
- Protein Microarrays
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033
- Research Institutions
- Hospitals and Clinics
- Diagnostic Centers
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Microarray Technology
- Biosensor Technology
- PCR-Integrated Biochips
- Nanotechnology-Based Chips
- Microfluidics-Based Systems
- Others
GLOBAL BIOCHIPS BASED IN-VITRO DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
